IP Library › Granted Patent US 11,628,132
Granted Patent B2
US 11,628,132 · App. 16/747,685 · Granted Apr 18, 2023

Minoxidil adjuvant therapies

Inventors: Ofer A. Goren (Irvine, CA); John McCoy (Irvine, CA)
Assignee: JUPITER WELLNESS, INC.
A61K8/4953A61K8/14A61K8/35A61K8/355A61K8/498A61K9/127A61K31/122A61K31/353A61K31/506A61P17/14A61Q7/00A61K2800/5922A61K2800/78
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,628,132
App. No.
16/747,685
Granted
Apr 18, 2023
Kind
B2
Abstract

Compositions and methods are disclosed herein for inducing (up-regulating) the expression of sulfotransferases in the hair follicles, e.g., the scalp. Increasing sulfotransferase is beneficial for metabolizing pro-drugs that require sulfonation to be activated, e.g., minoxidil sulfate is the active metabolite of minoxidil. A method for combining the compositions described herein with topical minoxidil to enhance minoxidil treatment for androgenetic alopecia is described. Additional methods and compositions include the use of retinoid X receptor agonists, retinoic acid receptor agonists, and nuclear receptor agonists in an RXR—NR heterodimer. Additional methods and compositions include the use of a topical solution containing an alkalinizing agent or an alkalinizing agent used with a penetration enhancer for up-regulating the sulfonating capacity of hair bearing skin, hair follicles, and/or keratinocyte cells. In addition, compositions and methods for increasing or decreasing the growth rate of hair follicles is disclosed by altering the intracellular pH.

Claims (26)

1. A composition for treating hair loss, improving hair growth, accelerating hair growth, increasing the sulfonating capacity of a hair follicle cell and/or keratinocyte cell, inducing sulfotransferase in a hair follicle, inducing expression of sulfotransferase, increasing sulfotransferase activity, increasing hair thickness and/or diameter, increasing hair growth rate, increasing hair density, accelerating hair growth, treating for alopecia, upregulating sulfotransferase, converting non-responders to minoxidil responders, and/or improving minoxidil response, the composition comprising:

an agent configured to induce expression of sulfotransferase in skin of a person exhibiting the effects of hair loss, wherein the agent includes a salt of minoxidil and

an inorganic sulfur source.

2. The composition of claim 1 , wherein:

the salt of minoxidil comprises a first ion and a second ion;

the first ion of the salt is an alkalinizing agent configured to raise intracellular pH of cells in an outer root sheath of a hair follicle; and

the second ion of the salt is a counter ion that is minoxidil.

3. The composition of claim 2 , wherein the alkalinizing agent includes any one or combination of: minoxidil bicarbonate, minoxidil citrate, minoxidil carbonate, minoxidil lactate, and minoxidil acetate.

4. The composition of claim 1 , further comprising a penetration enhancer.

5. The composition of claim 2 , wherein the alkalinizing agent is encapsulated, the encapsulation configured to any one or combination of:

increase the water solubility of the composition;

decrease the water solubility of the composition;

reduce the loss through degradation of therapeutic agent; and

promote penetration through the stratum corneum.

6. The composition of claim 2 , wherein the alkalinizing agent is placed in a liposome.

7. The composition of claim 1 , wherein the composition is configured to be administered by applying the composition at a predetermined frequency, administering the composition orally, injecting the composition, or providing the composition as an implant.

8. The composition of claim 1 , wherein the composition is configured to be administered by applying the composition at a predetermined frequency, wherein the composition further comprises a carrier, wherein the composition is formulated as any one or combination of a shampoo, a foam, ointment, spray, solution, gel, slow release capsule, oral tablet, dry shampoo, hair styling product, or exfoliating agent.

9. The composition of claim 1 , wherein the composition is formulated as a cosmetic product.

10. The composition of claim 1 , wherein the composition is formulated as any one or combination of a time release vehicle, a cream, a solution, a lotion, a serum, an ointment, a spray, an aerosol medium, a capsule, a shampoo, a gel, a foam, a cosmetic, a hair conditioner, a hair care product, a hair mask, a deodorant, an antiperspirant, a moisturizer, or a shaving cream or gel.

11. A kit for treating hair loss, improving hair growth, accelerating hair growth, increasing the sulfonating capacity of a hair follicle cell and/or keratinocyte cell, inducing sulfotransferase in a hair follicle, inducing expression of sulfotransferase, increasing hair thickness and/or diameter, increasing hair growth rate, increasing hair density, accelerating hair growth, treating for alopecia, upregulating sulfotransferase, converting non-responders to minoxidil responders, and/or improving minoxidil response, the kit comprising the composition of claim 1 and a dispenser, implant, or pill.

12. The kit of claim 11 , wherein the composition is formulated as any one or combination of a time release vehicle, a cream, a solution, a lotion, a serum, an ointment, a spray, an aerosol medium, a capsule, a shampoo, a gel, a foam, a cosmetic, a hair conditioner, a hair care product, a hair mask, a deodorant, an antiperspirant, a moisturizer, or a shaving cream or gel.

13. The composition of claim 1 , further comprising minoxidil.

14. The kit of claim 11 , wherein the composition further includes minoxidil.

15. The compositions of claim 1 , wherein treating for alopecia includes treating for alopecia areata, treating for chemotherapy induced alopecia, treating female and/or male pattern hair loss, and/or treating androgenetic alopecia.

16. The composition of claim 1 , wherein the inorganic sulfur source is chosen from the group consisting of cysteine, L-cysteine, hydrogen sulfide, elemental sulfur, sulfite, thiosulfate, polythionates, magnesium sulfate, sodium sulfate, and sodium metabisulfite.

17. The composition of claim 6 , wherein the liposome contains lecithin.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2022
From: APPLIED BIOLOGY, INC.
To: JUPITER WELLNESS INC.
Reel/Frame 060853/0245 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2020
From: GOREN, OFER A.; MCCOY, JOHN
To: APPLIED BIOLOGY, INC.
Reel/Frame 051650/0742 →
Continuity (7)
Continuation In Part 16593577 · Oct 4, 2019
Provisional Application 62895627 · Sep 4, 2019
Provisional Application 62849598 · May 17, 2019
Provisional Application 62800065 · Feb 1, 2019
Provisional Application 62756293 · Nov 6, 2018
Provisional Application 62741990 · Oct 5, 2018
Related Publication 20200214958A1 · Jul 9, 2020
Cited By (3)
US 12,377,098 US 12,527,729 US 12,533,309